For the first time, a novel neuroprotectant medication that may safeguard the brain from tissue damage has been linked to reduced death and disability among people diagnosed with stroke when added to standard treatment to restore blood flow.

The rate of death was four times lower among people who received the neuroprotectant medication, ApTOLL, compared to those receiving a placebo in a multi-nation study.